These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105. A clinical perspective of sepsis-associated delirium. Tsuruta R; Oda Y J Intensive Care; 2016; 4():18. PubMed ID: 27011789 [TBL] [Abstract][Full Text] [Related]
106. Neuroanatomy and Physiology of Brain Dysfunction in Sepsis. Mazeraud A; Pascal Q; Verdonk F; Heming N; Chrétien F; Sharshar T Clin Chest Med; 2016 Jun; 37(2):333-45. PubMed ID: 27229649 [TBL] [Abstract][Full Text] [Related]
107. Sepsis-associated encephalopathy: A review of literature. Molnár L; Fülesdi B; Németh N; Molnár C Neurol India; 2018; 66(2):352-361. PubMed ID: 29547154 [TBL] [Abstract][Full Text] [Related]
108. Sepsis-Associated Encephalopathy: From Delirium to Dementia? Chung HY; Wickel J; Brunkhorst FM; Geis C J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32150970 [TBL] [Abstract][Full Text] [Related]
109. Septic encephalopathy and septic encephalitis. Tauber SC; Eiffert H; Brück W; Nau R Expert Rev Anti Infect Ther; 2017 Feb; 15(2):121-132. PubMed ID: 27885885 [TBL] [Abstract][Full Text] [Related]
110. Biomarkers of Delirium in a Low-Risk Community-Acquired Pneumonia-Induced Sepsis. Tomasi CD; Vuolo F; Generoso J; Soares M; Barichello T; Quevedo J; Ritter C; Dal-Pizzol F Mol Neurobiol; 2017 Jan; 54(1):722-726. PubMed ID: 26768428 [TBL] [Abstract][Full Text] [Related]
111. Diagnostic value of NT-proCNP compared to NSE and S100B in cerebrospinal fluid and plasma of patients with sepsis-associated encephalopathy. Ehler J; Saller T; Wittstock M; Rommer PS; Chappell D; Zwissler B; Grossmann A; Richter G; Reuter DA; Nöldge-Schomburg G; Sauer M Neurosci Lett; 2019 Jan; 692():167-173. PubMed ID: 30423400 [TBL] [Abstract][Full Text] [Related]
116. Sepsis-associated encephalopathy: a vicious cycle of immunosuppression. Ren C; Yao RQ; Zhang H; Feng YW; Yao YM J Neuroinflammation; 2020 Jan; 17(1):14. PubMed ID: 31924221 [TBL] [Abstract][Full Text] [Related]
117. Sepsis-associated encephalopathy and septic encephalitis: an update. Tauber SC; Djukic M; Gossner J; Eiffert H; Brück W; Nau R Expert Rev Anti Infect Ther; 2021 Feb; 19(2):215-231. PubMed ID: 32808580 [TBL] [Abstract][Full Text] [Related]
118. Exploring Neuroprotective Agents for Sepsis-Associated Encephalopathy: A Comprehensive Review. Krzyzaniak K; Krion R; Szymczyk A; Stepniewska E; Sieminski M Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445958 [TBL] [Abstract][Full Text] [Related]
119. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Singer M; Deutschman CS; Seymour CW; Shankar-Hari M; Annane D; Bauer M; Bellomo R; Bernard GR; Chiche JD; Coopersmith CM; Hotchkiss RS; Levy MM; Marshall JC; Martin GS; Opal SM; Rubenfeld GD; van der Poll T; Vincent JL; Angus DC JAMA; 2016 Feb; 315(8):801-10. PubMed ID: 26903338 [TBL] [Abstract][Full Text] [Related]
120. Central role of microglia in sepsis-associated encephalopathy: From mechanism to therapy. Yan X; Yang K; Xiao Q; Hou R; Pan X; Zhu X Front Immunol; 2022; 13():929316. PubMed ID: 35958583 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]